This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sponsorship   |   Donate   |   JOIN!   |   Print Page   |   Report Abuse   |   Sign In
News & Press: General News

The Protecting Access to Medicare Act (PAMA)

Friday, March 20, 2020   (0 Comments)
Posted by: Joel Colon
Share |

The Protecting Access to Medicare Act (PAMA) was signed into law, in 2014, with the intention of basing clinical laboratory testing fees on market rates. Implementation of the law, however, has resulted in significant cuts in reimbursement for many clinical laboratory tests.

Click here to read ASHI's position statement.


Related links

Copyright 2008-2020© The American Society for Histocompatibility and Immunogenetics. All rights reserved. ASHI is professionally managed by Association Headquarters, a charter accredited association management company.

Association Management Software Powered by YourMembership  ::  Legal